A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus
A primary function of B lymphocytes is immunoglobulin production; however, the therapeutic benefit of B cell depletion in autoimmune diseases previously thought to be T cell mediated suggests that some B cells fulfill other roles in autoimmunity. We examined the recently identified human B1 cell population for T cell stimulatory activity. We found two kinds of B1 cells that are distinguished by multiple surface markers and distinct transcriptomic profiles. In both umbilical cord and adult peripheral blood, a CD11b(+) subset constitutes ~1 out of every 8-10 B1 cells, whereas a CD11b(-) subset constitutes the remaining B1 cells. These B1 cell populations differ functionally. CD11b(-) B1 cells spontaneously secrete much more IgM than CD11b(+) B1 cells. In contrast, CD11b(+) B1 cells express more CD86, and more efficiently stimulate allogeneic CD4(+) T cell expansion, than CD11b(-) B1 cells. The frequency of these CD11b(+) B1 cells is markedly elevated in lupus patients. CD11b(+) B1 cells in lupus patients express more CD86 and have increased T cell-stimulating activity in disease. This work distinguishes a novel, T cell-interacting B1 cell population whose abundance and activity may be a reflection of, and a therapeutic target in, autoimmune disease.
Errataetall: |
CommentIn: J Exp Med. 2012 Mar 12;209(3):433-4. - PMID 22412175 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:208 |
---|---|
Enthalten in: |
The Journal of experimental medicine - 208(2011), 13 vom: 19. Dez., Seite 2591-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Griffin, Daniel O [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.02.2012 Date Revised 21.10.2021 published: Print-Electronic GEO: GSE29717 CommentIn: J Exp Med. 2012 Mar 12;209(3):433-4. - PMID 22412175 Citation Status MEDLINE |
---|
doi: |
10.1084/jem.20110978 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM213295482 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM213295482 | ||
003 | DE-627 | ||
005 | 20231224021310.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1084/jem.20110978 |2 doi | |
028 | 5 | 2 | |a pubmed24n0711.xml |
035 | |a (DE-627)NLM213295482 | ||
035 | |a (NLM)22110167 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Griffin, Daniel O |e verfasserin |4 aut | |
245 | 1 | 2 | |a A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2012 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a GEO: GSE29717 | ||
500 | |a CommentIn: J Exp Med. 2012 Mar 12;209(3):433-4. - PMID 22412175 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A primary function of B lymphocytes is immunoglobulin production; however, the therapeutic benefit of B cell depletion in autoimmune diseases previously thought to be T cell mediated suggests that some B cells fulfill other roles in autoimmunity. We examined the recently identified human B1 cell population for T cell stimulatory activity. We found two kinds of B1 cells that are distinguished by multiple surface markers and distinct transcriptomic profiles. In both umbilical cord and adult peripheral blood, a CD11b(+) subset constitutes ~1 out of every 8-10 B1 cells, whereas a CD11b(-) subset constitutes the remaining B1 cells. These B1 cell populations differ functionally. CD11b(-) B1 cells spontaneously secrete much more IgM than CD11b(+) B1 cells. In contrast, CD11b(+) B1 cells express more CD86, and more efficiently stimulate allogeneic CD4(+) T cell expansion, than CD11b(-) B1 cells. The frequency of these CD11b(+) B1 cells is markedly elevated in lupus patients. CD11b(+) B1 cells in lupus patients express more CD86 and have increased T cell-stimulating activity in disease. This work distinguishes a novel, T cell-interacting B1 cell population whose abundance and activity may be a reflection of, and a therapeutic target in, autoimmune disease | ||
650 | 4 | |a Clinical Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a B7-2 Antigen |2 NLM | |
650 | 7 | |a CD11b Antigen |2 NLM | |
650 | 7 | |a CD86 protein, human |2 NLM | |
650 | 7 | |a ITGAM protein, human |2 NLM | |
650 | 7 | |a Immunoglobulin M |2 NLM | |
700 | 1 | |a Rothstein, Thomas L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of experimental medicine |d 1896 |g 208(2011), 13 vom: 19. Dez., Seite 2591-8 |w (DE-627)NLM000005967 |x 1540-9538 |7 nnns |
773 | 1 | 8 | |g volume:208 |g year:2011 |g number:13 |g day:19 |g month:12 |g pages:2591-8 |
856 | 4 | 0 | |u http://dx.doi.org/10.1084/jem.20110978 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 208 |j 2011 |e 13 |b 19 |c 12 |h 2591-8 |